TCL Archive Opdivo Study Shows 41 Percent One-Year Survival In Patients With at Least Two Past Therapies November 28, 2014
TCL Archive FDA, CMS Take Second Look at Drugs Given “Accelerated” Approval for Cancer February 21, 2003
TCL Archive NCI To Voluntarily Spends $196 Million On Breast Cancer; Will Require Reallocation November 13, 1992